MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1401 to 1420 of 166,322 approvalsPage 71 of 8317

Lenvatinib Mesilate Capsules

Approval Number: 国药准字H20253427
Registration: Feb 20, 2025

Guanfacine Hydrochloride Sustained-release Tablets

Approval Number: 国药准字H20253443
Registration: Feb 20, 2025

Phloroglucinol Injection

Approval Number: 国药准字H20253419
Registration: Feb 20, 2025

Potassium Sodium Hydrogen Citrate Granules

Approval Number: 国药准字H20253440
Registration: Feb 20, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253425
Registration: Feb 20, 2025

Phenylephrine Hydrochloride Injection

Approval Number: 国药准字H20253388
Registration: Feb 20, 2025

Amphotericin B Liposome for Injection

Approval Number: 国药准字HC20250001
Registration: Feb 20, 2025
台湾微脂体股份有限公司

Ziprasidone Hydrochloride Capsules

Approval Number: 国药准字H20253410
Registration: Feb 20, 2025

Risperidone for Depot Suspension

Approval Number: 国药准字H20253407
Registration: Feb 20, 2025

Risperidone for Depot Suspension

Approval Number: 国药准字H20253406
Registration: Feb 20, 2025

Mirabegron Sustained-release Tablets

Approval Number: 国药准字H20253412
Registration: Feb 20, 2025

Levocarnitine Injection

Approval Number: 国药准字H20253437
Registration: Feb 20, 2025

Betamethasone Sodium Phosphate Injection

Approval Number: 国药准字H20253417
Registration: Feb 20, 2025

Tenapanor Hydrochloride Tablets

Approval Number: 国药准字HJ20250020
Registration: Feb 20, 2025

Esomeprazole Magnesium Enteric-coated Capsules

Approval Number: 国药准字H20253416
Registration: Feb 20, 2025

Oxytocin Injection

Approval Number: 国药准字H20253395
Registration: Feb 20, 2025

Minoxidil Liniment

Approval Number: 国药准字H20253431
Registration: Feb 20, 2025

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Approval Number: 国药准字H20253383
Registration: Feb 20, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253404
Registration: Feb 20, 2025

Tadalafil Tablets

Approval Number: 国药准字H20253436
Registration: Feb 20, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.